Lab staff are working long unpaid hours to reduce the impact Covid is having on cancer research.
Dr Alba Rodriguez-Meira is losing motivation for her research because she's missed so many social occasions while working longer hours in the labIt's pretty normal for lab scientists to work long, unsociable hours to run experiments.
Laboratories had been closed for almost four months and Alba worked more than 90 hours a week - that's 13 hours a day, including weekends - to try to get her leukaemia research back on track at the University of Oxford."That was fine during the first month but it becomes a bit disruptive in terms of life quality if you try to do it for much longer," Alba says.
"Working under these circumstances has made me lose a bit of that. And I am sometimes so, so, absolutely tired."Social distancing rules mean that even though labs have reopened, not everyone can be there at the same time. "We don't have the luxury of time - that's the truth - to wait for two extra years," says Amani Liaquat, 23, who has an aggressive cancerous brain tumour known as aAmani was diagnosed in April 2020 and doctors have said she has between 12 and 18 months to live.Amani "can't really put into words" how grateful she is to cancer researchers
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Covid: Drakeford set for Covid talks after Welsh election winMark Drakeford returns to work after Labour's Welsh election win to consider easing lockdown rules.
Read more »
Covid in Scotland: Inspectors highly critical of Covid-hit care homeDying residents' health needs were 'neglected' at the care home in Midlothian where 15 died with Covid.
Read more »
Covid:19: Nisra records slight increase in NI Covid deathsCovid-19 was mentioned on the death certificates of eight people in NI up to Friday 30 April.
Read more »
Antibody drug neutralizes virus variants in lab study; COVID-19 antibodies detectable 12 months after infectionThe following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus. An experimental monoclonal antibody treatment for COVID-19 being developed by Eli Lilly and Co and AbCellera Biologics Inc can 'potently' neutralize numerous coronavirus variants, including those first identified in the UK, Brazil, South Africa, California and New York, scientists have found in test tube experiments. The antibody - known as LY-CoV1404 or LY3853113 - works by attaching itself to a place on the virus that has shown few signs of mutating, which means the drug is likely to retain its effectiveness over time, the researchers said in a report posted on Friday on bioRxiv ahead of peer review.
Read more »
Dr. Scott Gottlieb: Here’s why it’s important, even for young Americans, to get second Covid shot'If you really want to get a durable effect from the vaccine, you really should get the second dose,' former FDA chief Dr. Scott Gottlieb said.
Read more »
Covid-19 vaccinations for young teens could be available as soon as Thursday, FDA predictsThe CDC is expected to sign off on the move Wednesday, making Thursday the first day shots could be available for children 12 to 15 years old.
Read more »